MustGrow Biologics's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 29.56.
MustGrow Biologics's Days Inventory for the
three
months ended in Mar. 2026 was 680.23.
MustGrow Biologics's Days Payable for the
three
months ended in Mar. 2026 was 0.
Therefore, MustGrow Biologics's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 709.79.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
MustGrow Biologics Cash Conversion Cycle Related Terms
MustGrow Biologics Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGROF vs CTVA, CF, MOS: Cash Conversion Cycle Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Cash Conversion Cycle vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
MustGrow Biologics's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics (MGROF) has a Cash Conversion Cycle of 709.79 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on MustGrow Biologics and its competitors.
Is MustGrow Biologics' Cash Conversion Cycle too high?
MustGrow Biologics' current Cash Conversion Cycle is 709.79. The Agriculture industry median Cash Conversion Cycle is 100.08. MustGrow Biologics' value of 709.79 is 609.2% above this industry median. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Cash Conversion Cycle compare to CTVA and CF?
MustGrow Biologics' Cash Conversion Cycle of 709.79 can be compared against companies in the Agriculture industry. The industry median Cash Conversion Cycle is 100.08. MustGrow Biologics' value of 709.79 is 609.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Agriculture company?
The median Cash Conversion Cycle among Agriculture companies is 100.08, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MustGrow Biologics's current Cash Conversion Cycle of 709.79 is 609.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on MustGrow Biologics and its competitors. For the Agriculture industry, the median Cash Conversion Cycle is 100.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current Cash Conversion Cycle is 709.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Cash Conversion Cycle of 709.79. The current Cash Conversion Cycle is 709.79 and 609.2% above the Agriculture industry median of 100.08. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Cash Conversion Cycle is 709.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score
Get the complete analysis for MGROF
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
